.jpg)
Vsling
The Next Frontier in Heart Failure Treatment
About Us
Cardiac Success is developing the V-sling device to improve the lives of the millions of patients who, despite guidance-directed medical therapy, continue to suffer and deteriorate from Heart Failure with Reduced Ejection Fraction (HFrEF). The V-sling is a transcatheter ventricular repair device designed based on a successful surgical papillary muscle approximation procedure.
Vsling
Ventricular Repair Device Treating
Heart Failure with Left Ventricle Dilation
Heart Failure
There are currently about 8 million heart failure patients worldwide whose lives could potentially be improved by treatment with the V-sling device. Cardiac Success aims to treat patients suffering from HFrEF (Heart Failure with reduced Ejection Fraction), a condition typically associated with ventricular dilation, papillary muscle dislocation, and low ejection fraction.
Our Technology
V-Sling
The V-sling is a transcatheter ventricular repair device designed based on a successful surgical papillary muscle approximation procedure.
V-Sling Unique Benefits
-
Restores the conical shape of the Left Ventricle
-
Eliminates leaflet tethering
-
Adjustable implant size for optimized Left Ventricle repair
-
Safe anchorless implant, no endocardium penetration
-
Does not block future interventions
News
Israeli Medical Device Startup, Cardiac Success Ltd.,
Closes US $5.2M Series A Financing.
The round was led by 415 CAPITAL, a specialist medical technology venture capital firm who was joined by an unnamed strategic investor and global leader in structural heart interventions. Proceeds will be used for pre-clinical testing and the completion of a First-in-Human trial of the company’s innovative “V-sling” heart failure therapy.
Cardiac Success Awarded €10M in Grants and Equity Investment from the European Innovation Council
Funds to accelerate the clinical development of the novel “V-sling” system, a transcatheter ventricular repair implant designed to provide a new therapy for heart failure patients.
Our Team
Boaz Manash,
MSc, MBA
CEO
Experienced R&D leader in start-ups and at large medical device companies. Previously leader of the promising Mitral program in Edwards Lifesciences, the Sapien M3
David Neustadter, PhD
CTO & Founder
Over 20 years experience in medical device design. Co-founder, CTO and VP R&D in 2 previous medical device startup companies.
Dr. Shimon Eckhouse
Chairman & Co-Founder
An inventor, active entrepreneur and investor in MedTech companies. Former chairman and co-founder of Syneron Medical (acquired by APAX), founder, chairman and CEO of Lumenis and co-founder of Ventor (acquired by Medtronic).
Lea Waisman Shaler,
MSc, MBA
COO
15 years of experience in design, development, and management of R&D projects in interventional cardiology and gastroenterology.
Prof. Rafael Beyar
CMO
Interventional cardiologist, an established entrepreneur, former director and CEO of Rambam Medical Center. Successfully founded and sold 2 major cardiovascular companies.
This project has received funding from the European Union’s Horizon Europe under grant agreement
No. 190122502